Abstract
A human invitro cardiac tissue model would be a significant advancement for understanding, studying, and developing new strategies for treating cardiac arrhythmias and related cardiovascular diseases. We developed an invitro model of three-dimensional (3D) human cardiac tissue by populating synthetic filamentous matrices with cardiomyocytes derived from healthy wild-type volunteer (WT) and patient-specific long QT syndrome type 3 (LQT3) induced pluripotent stem cells (iPS-CMs) to mimic the condensed and aligned human ventricular myocardium. Using such a highly controllable cardiac model, we studied the contractility malfunctions associated with the electrophysiological consequences of LQT3 and their response to a panel of drugs. By varying the stiffness of filamentous matrices, LQT3 iPS-CMs exhibited different level of contractility abnormality and susceptibility to drug-induced cardiotoxicity.
| Original language | English |
|---|---|
| Pages (from-to) | 1367-1377 |
| Number of pages | 11 |
| Journal | Biomaterials |
| Volume | 35 |
| Issue number | 5 |
| DOIs | |
| State | Published - Feb 2014 |
Keywords
- Cardiac contractility
- Cardiac disease model
- Drug testing
- Induced pluripotent stem cells
- Long QT syndrome
- Two-photon initiated polymerization
Fingerprint
Dive into the research topics of 'Three-dimensional filamentous human diseased cardiac tissue model'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver